These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1674093)

  • 1. Mazindol in long-term treatment of narcolepsy.
    Alvarez B; Dahlitz M; Grimshaw J; Parkes JD
    Lancet; 1991 May; 337(8752):1293-4. PubMed ID: 1674093
    [No Abstract]   [Full Text] [Related]  

  • 2. Mazindol in the treatment of narcolepsy.
    Parkes JD; Schachter M
    Acta Neurol Scand; 1979 Oct; 60(4):250-4. PubMed ID: 525256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review.
    Nittur N; Konofal E; Dauvilliers Y; Franco P; Leu-Semenescu S; Cock VC; Inocente CO; Bayard S; Scholtz S; Lecendreux M; Arnulf I
    Sleep Med; 2013 Jan; 14(1):30-6. PubMed ID: 23036267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of mazindol on narcolepsy.
    Iijima S; Sugita Y; Teshima Y; Hishikawa Y
    Sleep; 1986; 9(1 Pt 2):265-8. PubMed ID: 3704452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine, mazindol, and fencamfamin in narcolepsy.
    Shindler J; Schachter M; Brincat S; Parkes JD
    Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1167-70. PubMed ID: 2859077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of mazindol in Gélineau's disease. Apropos of 10 cases].
    Vespignani H; Weber M; Atlas P; Barroche G
    Rev Electroencephalogr Neurophysiol Clin; 1986 Oct; 16(3):317-22. PubMed ID: 3809694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of mazindol in the treatment of narcolepsy.
    Vespignani H; Barroche G; Escaillas JP; Weber M
    Sleep; 1984; 7(3):274-5. PubMed ID: 6484432
    [No Abstract]   [Full Text] [Related]  

  • 8. Mazindol: a risk factor for pulmonary arterial hypertension?
    Konofal E; Benzouid C; Delclaux C; Lecendreux M; Hussey E
    Sleep Med; 2017 Jun; 34():168-169. PubMed ID: 28522087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Narcolepsy].
    Lange KW
    Dtsch Med Wochenschr; 1990 Aug; 115(33):1244-50. PubMed ID: 2201510
    [No Abstract]   [Full Text] [Related]  

  • 10. Selegiline in narcolepsy.
    Roselaar SE; Langdon N; Lock CB; Jenner P; Parkes JD
    Sleep; 1987 Oct; 10(5):491-5. PubMed ID: 3120270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mazindol for nocturnal enuresis.
    Tiptaft RC; Woodhouse CR; Badenoch DF
    Br J Urol; 1984 Dec; 56(6):641-3. PubMed ID: 6534482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mazindol in the control of micturition.
    Woodhouse CR; Tiptaft RC
    Br J Urol; 1983 Dec; 55(6):636-8. PubMed ID: 6360295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical use of mazindol in the treatment of essential obesity].
    Guazzelli R; Piazzini M; Conti C; Papi L; Strazzulla G; Matassi L
    Clin Ter; 1987 Mar; 120(5):385-91. PubMed ID: 2953538
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity].
    Delitala G; Alagna S; Masala A
    Clin Ter; 1977 Jun; 81(6):547-54. PubMed ID: 884939
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquired narcolepsy in an acromegalic patient who underwent pituitary irradiation.
    Dempsey OJ; McGeoch P; de Silva RN; Douglas NJ
    Neurology; 2003 Aug; 61(4):537-40. PubMed ID: 12939432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in the psychopharmacological management of the narcoleptic patient].
    Salín-Pascual RJ; de la Fuente JR
    Acta Psiquiatr Psicol Am Lat; 1985 Mar; 31(1):62-8. PubMed ID: 4050495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of mazindol (Teronac) with diethylpropion in the treatment of exogenous obesity.
    Murphy JE; Donald JF; Molla AL; Crowder D
    J Int Med Res; 1975; 3(3):202-6. PubMed ID: 162676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy.
    Coakley JH; Moorcraft J; Hipkin LJ; Smith CS; Griffiths RD; Edwards RH
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1551-7. PubMed ID: 3221222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity.
    Enzi G; Baritussio A; Marchiori E; Crepaldi G
    J Int Med Res; 1976; 4(5):305-18. PubMed ID: 1028632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AN 448 Sandoz (Mazindol) in the treatment of obesity.
    Wallace AG
    Med J Aust; 1976 Mar; 1(11):343-5. PubMed ID: 775265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.